Roger S. McIntyre, MD, FRCPC
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
Original Research
Vortioxetine and Cognition in Working Patients With MDD
January 25, 2017
Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...
Article
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d
June 4, 2015
The authors of this article conducted a post hoc analysis of data from 8 short-term and 1 longer-term double-blind, placebo-controlled studies of patients with major depressive disorder treated with...
Article
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder
February 26, 2015
In this article by McIntyre and colleagues, relapse rates and predictors of relapse were evaluated in 2 randomized, placebo-controlled trials of desvenlafaxine for major depressive disorder.
